OPKO Health (NASDAQ:OPK) executives said the company exited 2025 with “tremendous momentum,” citing efforts to reposition its ...
Clemson University announced today a strategic collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services, to improve healthcare access, expand educational ...
Labcorp expanded its partnership with PathAI to offer its FDA-cleared digital pathology platform at the life science giant’s U.S. network of anatomical pathology labs and participating hospitals.
Labcorp’s Q4 results came in below Wall Street’s revenue expectations, leading to a negative market reaction, while ...
Last week, readers were most interested in a story about a deal between QuidelOrtho and Shenzhen Lifotronic Technology covering immunoassays.
Labcorp said it will be using the company's FDA-cleared AISight Dx platform across its national network of anatomic pathology labs and hospital collaborations.
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results